Leonard Valentino: Excited to Share The New Perspectives on Hemophilic Arthropathy
Leonard Valentino, Former President and CEO of NBDF, President of WFH USA, recenlty shared a post on LinkedIn about a recent article he and Yesim Dargaud co-authored, published in Haematologica, adding:
”I’m excited to share our latest review in the journal Haematologica: ‘Mechanisms of Blood-Induced Joint Disease in Hemophilia and Potential Novel Targets for Interventions.’
For decades, hemophilic arthropathy has been viewed primarily as a consequence of recurrent joint bleeding. In this review, we explore a broader perspective: hemarthrosis is the initiating event, but iron-driven biological processes are what ultimately fuel chronic joint degeneration.
Our analysis integrates historical observations with emerging insights from molecular biology and single-cell genomics to propose an updated model of blood-induced joint disease.
We highlight how iron deposition following bleeding triggers oxidative stress, inflammation, synovial remodeling, vascular changes, and cartilage injury that can persist long after the bleeding episode itself.
Several emerging mechanisms deserve particular attention:
- Iron-driven oxidative stress as a central driver of synovial and cartilage pathology.
- Endothelial ferroptosis and vascular remodeling as potential contributors to ongoing joint vulnerability and re-bleeding.
- The iRhom2/ADAM17/TNF-α pathway as a key mediator of synovial inflammation and bone loss.
- Activated mast cells and endothelial–fibroblast crosstalk as newly recognized components of the hemophilic joint microenvironment.
- The TNXB–AKT pathway as a potentially important cartilage-protective mechanism that may offer new opportunities for chondroprotection.
The central message of our review is straightforward: preventing bleeding remains essential, but preventing arthropathy may require targeting the biological consequences of blood exposure within the joint.
Looking ahead, therapeutic strategies directed at iron handling, oxidative stress, ferroptosis, inflammatory signaling, fibroblast reprogramming, and cartilage survival pathways may complement modern hemostatic therapies and help preserve lifelong joint health.
I am grateful to my co-author, Dr. Yesim Dargaud, for her collaboration on this work and look forward to the discussions that these concepts may stimulate across the hemophilia community.”
Title: Mechanisms of blood-induced joint disease in hemophilia and potential novel targets for interventions
Authors: Leonard Valentino, Yesim Dargaud

Stay updated on all scientific advances with Hemostasis Today.
-
Nov 16, 2026, 15:35Jim Hoffman: Could Blood Purification Change the Fight Against Cancer?
-
Nov 16, 2026, 15:16How Do Artificial Hearts Affect Platelet Function? – Platelets Journal
-
Nov 16, 2026, 15:10Assessing Coagulation Activation in DOAC – Treated Patients – JTH
-
Nov 16, 2026, 15:00Davide Antonio Mei: Should Anticoagulation Continue After AF Ablation?
-
Nov 16, 2026, 14:55Danielle Boyle: Beyond Platelet Counts – Why Patient Stories Matter
-
Nov 16, 2026, 14:28Jan Sloves: The Future of Vascular Ultrasound
-
Nov 16, 2026, 13:49Bahman Rasouli: A Rare Vascular Manifestation of Recurrent Papillary Thyroid Carcinoma
-
Nov 16, 2026, 13:28Muhammad Danyal: Platelet Patterns in Hepatitis B and C
-
Nov 16, 2026, 12:52Frank Nocken: Alzheimer’s Research Expands Beyond Amyloid-Based Treatments